Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients

A correlation between impaired bone metabolism, chronic kidney disease, and cardiovascular diseases (CVD) has been suggested. This study aimed to compare the effects of denosumab and alendronate, two anti-resorptive agents, on cardiovascular and renal outcomes in osteoporotic patients. Propensity sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Tsuen-Wei, Hsu, Chien-Ning, Wang, Shih-Wei, Huang, Chiang-Chi, Li, Lung-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678904/
https://www.ncbi.nlm.nih.gov/pubmed/31261703
http://dx.doi.org/10.3390/jcm8070932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678904/
https://www.ncbi.nlm.nih.gov/pubmed/31261703
http://dx.doi.org/10.3390/jcm8070932

Ejemplares similares